Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 3/10

vs
industry
vs
history
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» VSCP's 10-Y Financials

Financials (Next Earnings Date: 2017-03-30)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q3 2015

VSCP Guru Trades in Q3 2015

Jim Simons 17,590 sh (+9.32%)
» More
Q4 2015

VSCP Guru Trades in Q4 2015

Jim Simons 54,790 sh (+211.48%)
» More
Q1 2016

VSCP Guru Trades in Q1 2016

Jim Simons 62,090 sh (+13.32%)
» More
Q2 2016

VSCP Guru Trades in Q2 2016

Jim Simons Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with VSCP

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices  
Compare:OTCPK:NIMU, NAS:AMDA, NAS:EVAR, AMEX:HRT, OTCPK:MRIC, OTCPK:CRVW, OTCPK:GIDYL, NAS:LLIT, NAS:PHMD, OTCPK:ZYXI, OTCPK:IGNG, OTCPK:SMLR, OTCBB:NAOV, NAS:AHPI, AMEX:XTNT, NAS:DYNT, NAS:MDVX, OTCPK:MPHMF, OTCPK:PBIO, OTCPK:AROSF » details
VirtualScopics Inc is a provider of quantitative imaging solutions for clinical trials serving the pharmaceutical, biotechnology and medical device industries.

VirtualScopics Inc. is a provider of quantitative imaging for clinical trials serving the pharmaceutical, biotechnology and medical device industries. The Company has developed a software platform for analysis and modeling of both structural and functional medical images. This platform provides information about the biological activity of drugs and devices in clinical trial patients. VirtualScopics is an imaging core lab providing central reads and quantitative imaging solutions for drug and medical device clinical trials for the areas of oncology, rheumatoid arthritis, osteoarthritis, neurology, and cardiovascular studies utilizing MRI, PET, CT, Ultrasound, and X-ray imaging modalities. The Company's image-based measurement and visualization tools enable automated and reproducible measurement of minute changes that occur in anatomic structures in musculoskeletal, oncological, cardiological and neurological diseases. The Company's image analysis provides a degree of accuracy and reproducibility that cannot be duplicated by manual techniques. The Company's quantitative imaging replaces subjective evaluation. It has developed a suite of patented semi-automated tools for the identification and measurement of carotid plaques. Evaluating diseases such as multiple sclerosis (MS), epilepsy, and Alzheimer's requires the identification and measurement of neurological structures and lesions. The Company's competition is largely comprised of a limited number of university research centers that are working on developing the next generation of image analysis tools. The Company's main customers are Novartis, Merck Serono and Amgen. The Company's main competitors are clinical research organizations (CROs) providing clinical trial services to pharmaceutical companies. Healthcare in the United States is heavily regulated by the federal government, and by state and local governments.

Ratios

vs
industry
vs
history

Buy Back

vs
industry
vs
history

Valuation & Return

vs
industry
vs
history

More Statistics

Revenue (TTM) (Mil) $12.72
EPS (TTM) $ -0.41
Short Percentage of Float1.45%
52-Week Range $1.73 - 6.65
Shares Outstanding (Mil)3.01
» More Articles for VSCP

Headlines

Articles On GuruFocus.com

More From Other Websites
VIRTUALSCOPICS, INC. Files SEC form 8-K, Termination of a Material Definitive Agreement, Completion... May 12 2016
VIRTUALSCOPICS, INC. Files SEC form 10-Q, Quarterly Report May 11 2016
BIOTELEMETRY, INC. ANNOUNCES THE COMPLETION OF ITS ACQUISITION OF VIRTUALSCOPICS, INC. May 11 2016
BioTelemetry, Inc. Announces Results of Tender Offer for Shares of VirtualScopics, Inc. May 10 2016
VirtualScopics, Inc. Board Determines Gastineau Partners Proposal Not Reasonably Expected to Lead to... May 09 2016
VirtualScopics, Inc. Board Determines Gastineau Partners Proposal Not Reasonably Expected to Lead to... May 09 2016
BIOTELEMETRY, INC. SIGNS DEFINITIVE AGREEMENT TO ACQUIRE VIRTUALSCOPICS, INC. Apr 12 2016
BioTelemetry, Inc. Commences Previously Announced Tender Offer to Acquire VirtualScopics, Inc. Apr 08 2016
VIRTUALSCOPICS, INC. Financials Mar 31 2016
VirtualScopics, Inc. :VSCP-US: Earnings Analysis: Q4, 2015 By the Numbers Mar 29 2016
VirtualScopics, Inc. :VSCP-US: Earnings Analysis: 2015 By the Numbers Mar 29 2016
VIRTUALSCOPICS, INC. Files SEC form 8-K, Regulation FD Disclosure Mar 29 2016
VirtualScopics, Inc. Cancels Conference Call Due To Recent Announcement Of The Definitive Agreement... Mar 29 2016
VirtualScopics, Inc. Cancels Conference Call Due To Recent Announcement Of The Definitive Agreement... Mar 29 2016
VIRTUALSCOPICS INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP... Mar 28 2016
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation as to Whether the Sale of... Mar 28 2016
VIRTUALSCOPICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of... Mar 25 2016
BioTelemetry, Inc. Signs Definitive Agreement to Acquire VirtualScopics, Inc. Mar 25 2016
VirtualScopics, Inc. Schedules 2015 Fourth Quarter And Full Year Financial Results Press Release,... Feb 29 2016
VIRTUALSCOPICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events,... Jan 22 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)